Advertisement

Neurological Sciences

, Volume 39, Issue 9, pp 1551–1557 | Cite as

Three novel mutations in 20 patients with hereditary spastic paraparesis

  • Mehmet Bugrahan Duz
  • Selcuk Dasdemir
  • Aysel Kalayci Yigin
  • Mehmet Ali Akalin
  • Mehmet Seven
Original Article

Abstract

Hereditary spastic paraparesis (HSP) constitutes both genetic and clinically heterogeneous group of upper motor neuron diseases. Half of the individuals with autosomal dominant (AD) HSP have mutations in SPAST, ATL1, and REEP1 genes. This study was conducted to elucidate the genetic etiology of patients with the pure type AD-HSP diagnosis. The patient group consisted of 23 individuals from 6 families in Turkey. In the first step of work, Sanger sequencing (SS) was performed in ATL1, SPAST, and REEP1 genes and the second phase whole-exome sequencing (WES) was performed following SS analysis for the patients with no detected mutations in these genes. The results of this study revealed that in ATL1, 6 patients have previously reported c.776C > A mutation and 6 patients have novel c.470 T > C mutation. In SPAST, 3 patients have novel c.1072G > C mutation and 2 patients have novel c.1099-1G > C mutation. WES was performed in three patients, who had no detected mutation in these genes with SS analysis. In this approach, as previously reported c.1859 T > C mutation in KIAA0196 was detected, and it was confirmed with the patient’s relatives by SS. In three of patients, no HSP-associated variant could be identified in SS and WES. With this study, the molecular genetic etiology in 20 of 23 (87%) individuals that were included in this study with the utilization of SS and WES was elucidated. Utilization of SS and WES methods have enabled the identification of genetic etiology of HSP further with appropriate genetic counseling that was provided to the patients.

Keywords

Hereditary spastic paraparesis Novel mutation Whole-exome sequencing Genetic heterogeneity 

Notes

Acknowledgements

We are grateful to the families and individuals for their participation in this study and to the physicians and staff members of the Department of Medical Genetics and Neurology, Cerrahpaşa Medical School, Istanbul University-Cerrahpaşa, for their involvement in the management of the patients. Also, we thank Dr. Selcuk Sozer Tokdemir for the valuable inputs and reviews.

Funding information

This work was supported by the Istanbul University Scientific Research Projects Unit. (Grant number: 22323).

Compliance with ethical standards

The study protocol was approved by the Istanbul University Institutional Review Board for Research with Human Participants. Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10072_2018_3454_MOESM1_ESM.docx (15 kb)
ESM 1 (DOCX 14 kb)
10072_2018_3454_MOESM2_ESM.docx (210 kb)
ESM 2 (DOCX 210 kb)
10072_2018_3454_MOESM3_ESM.docx (17 kb)
ESM 3 (DOCX 17 kb)

References

  1. 1.
    Finsterer J, Löscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G (2012) Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 318(1–2):1–18CrossRefPubMedGoogle Scholar
  2. 2.
    Fink JK (2014) Hereditary spastic paraplegia overview. GenereviewsGoogle Scholar
  3. 3.
    Loureiro JL, Brandão E, Ruano L, Brandão AF, Lopes AM, Thieleke-Matos C, Miller-Fleming L, Cruz VT, Barbosa M, Silveira I, Stevanin G, Pinto-Basto J, Sequeiros J, Alonso I, Coutinho P (2013) Autosomal dominant spastic paraplegias: a review of 89 families resulting from a Portuguese survey. JAMA Neurol 70(4):481–487CrossRefPubMedGoogle Scholar
  4. 4.
    Mészárosová AU, Putzová M, Čermáková M, Vávrová D, Doležalová K, Smetanová I, Stejskal D, Beetz C, Seeman P (2016) SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia. J Hum Genet 61(10):845–850CrossRefPubMedGoogle Scholar
  5. 5.
    Richard S, Lavie J, Banneau G, Voirand N, Lavandier K, Debouverie M (2017) Hereditary spastic paraplegia due to a novel mutation of the REEP1 gene: case report and literature review. Medicine (Baltimore) 96(3):e5911CrossRefGoogle Scholar
  6. 6.
    Posey JE, Rosenfeld JA, James RA, Bainbridge M, Niu Z, Wang X, Dhar S, Wiszniewski W, Akdemir ZH, Gambin T, Xia F, Person RE, Walkiewicz M, Shaw CA, Sutton VR, Beaudet AL, Muzny D, Eng CM, Yang Y, Gibbs RA, Lupski JR, Boerwinkle E, Plon SE (2016) Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med 18(7):678–685CrossRefPubMedGoogle Scholar
  7. 7.
    Jahic A, Kreuz F, Zacher P, Fiedler J, Bier A, Reif S, Rieger M, Krüger S, Beetz C, Plaschke J (2014) A novel strumpellin mutation and potential pitfalls in the molecular diagnosis of hereditary spastic paraplegia type SPG8. J Neurol Sci 347(1–2):372–374CrossRefPubMedGoogle Scholar
  8. 8.
    Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M (2017) Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia. PLoS One 12(3):e0174667CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, Abdellateef M, Rosti B, Scott E, Mansour L, Masri A, Kayserili H, Al-Aama JY, Abdel-Salam GM, Karminejad A, Kara M, Kara B, Bozorgmehri, Ben-Omran T, Mojahedi F, Mahmoud IG, Bouslam N, Bouhouche A, Benomar A, Hanein S, Raymond L, Forlani S, Mascaro M, Selim L, Shehata N, Al-Allawi N, Bindu PS, Azam M, Gunel M, Caglayan A, Bilguvar K, Tolun A, Issa MY, Schroth J, Spencer EG, Rosti RO, Akizu N, Vaux KK, Johansen A, Koh AA, Megahed H, Durr A, Brice A, Stevanin G, Gabriel SB, Ideker T, Gleeson JG (2014) Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 343(6170):506–511CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Schüle R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, Otto S, Winner B, Schöls L (2006 Aug 8) The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 67(3):430–434CrossRefPubMedGoogle Scholar
  11. 11.
    Rainier S, Sher C, Reish O, Thomas D, Fink JK (2006) De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol 63(3):445–447CrossRefPubMedGoogle Scholar
  12. 12.
    Zhao GH, Liu XM (2017) Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: a literature reanalysis. Transl Neurodegener 6:9CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tessa A, Casali C, Damiano M, Bruno C, Fortini D, Patrono C, Cricchi F, Valoppi M, Nappi G, Amabile GA, Bertini E, Santorelli FM (2002) SPG3A: an additional family carrying a new atlastin mutation. Neurology 59(12):2002–2005CrossRefPubMedGoogle Scholar
  14. 14.
    Sauter SM, Engel W, Neumann LM, Kunze J, Neesen J (2004) Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late-onset forms of HSP linked to the SPG3A locus. Hum Mutat 23(1):98CrossRefPubMedGoogle Scholar
  15. 15.
    Dürr A, Tallaksen C, Depienne C (2012) Spastic Paraplegia 4. GenereviewsGoogle Scholar
  16. 16.
    Hedera P (2014) Spastic Paraplegia 3A. GenereviewsGoogle Scholar
  17. 17.
    Yu AC, Chan AY, Au WC, Shen Y, Chan TF, Chan HE (2016) Whole-genome sequencing of two probands with hereditary spastic paraplegia reveals novel splice-donor region variant and known pathogenic variant in SPG11. Cold Spring Harb Mol Case Stud 2(6):a001248CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical Genetics, Cerrahpaşa Medical SchoolIstanbul University-CerrahpaşaFatihTurkey
  2. 2.Department of Neurology, Cerrahpaşa Medical SchoolIstanbul University-CerrahpaşaFatihTurkey

Personalised recommendations